Genetic predisposition to 4NQO-induced tongue carcinogenesis in the rat

Medical Principles and Practice

Volumn 14, Issue 5, 2005, Pages 297-305

  Tanuma, Jun Ichi ^a   Hirano, Masato ^a   Hirayama, Yoshikazu ^a   Semba, Ichiro ^a   Ogawa, Kotaro ^a   Shisa, Hayase ^b   Hiai, Hiroshi ^c   Kitano, Motoo ^d  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b SAITAMA CANCER CENTER   (Japan)

^c Shiga Medical Center   (Japan)

^d Nakatsu Municipal Hospital   (Japan)

Author keywords

4 Nitroquinoline 1 oxide; Genetic susceptibility; Loss of heterozygosity; Quantitative trait loci; Rat; Tongue cancer

Indexed keywords

4 NITROQUINOLINE 1 OXIDE;

ALLELE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMOSOMAL LOCALIZATION; CONTROLLED STUDY; DNA METHYLATION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC PREDISPOSITION; HETEROZYGOSITY LOSS; MULTIFACTORIAL GENETIC DISORDER; NONHUMAN; POINT MUTATION; QUANTITATIVE TRAIT LOCUS MAPPING; RAT; RAT STRAIN; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA;

4-NITROQUINOLINE-1-OXIDE; ANIMALS; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; GENETIC PREDISPOSITION TO DISEASE; LOSS OF HETEROZYGOSITY; MODELS, ANIMAL; MODELS, GENETIC; MULTIFACTORIAL INHERITANCE; POLYMERASE CHAIN REACTION; RATS; TONGUE NEOPLASMS;

EID: 23844500645     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086926     Document Type: Article

References (52)

1. Foulkes WD, Brunet JS, Kowalski LP, Narod SA, Franco EL: Family history of cancer is a risk factor for squamous cell carcinoma of the head and neck in Brazil: a case control study. Int J Cancer 1990;62:847-851.
2. Franceschi S, Barra S, Vecchia C, Bidoli E, Negri E, Talamini R: Risk factors for cancer of the tongue and mouth: a case-control study from Northern Italy. Cancer 1992;70:2227-2233.
3. Houck JR, Romano PJ, Batholomew M, Smith P: Do histocompatibility antigens influence the risk of head and neck carcinoma? Cancer 1992;69:2327-2332.
4. Goldstein AM, Blot WJ, Greenberg RS, Schoenberg JB, Austin DF, Preston-Martin S, Winn DM, Bernstein L, McLaughlin JK, Fraumeni JF Jr: Familial risk in oral and pharyngeal cancer. Eur J Cancer B Oral Oncol 1994;308:319-322.
5. Yu GP, Zhang ZF, Hsu TC, Spitz MR, Schantz SP: Family history of cancer, mutagen sensitivity, and increased risk of head and neck cancer. Cancer Lett 1999;146:93-101.
6. Kitano M, Hatano H, Shisa H: Strain difference of susceptibility to 4-nitroquinoline 1-oxide-induced tongue carcinoma in rats. Jpn J Cancer Res 1992;83:843-850.
7. Kitano M, Hirayama Y, Tanuma J, Matsuuchi H, Li T-J, Semba I, Kokubu T, Hatano H, Tada M, Kobayashi Y, Shisa H: Genetic controls of susceptibility and resistance to 4-nitroquinoline 1-oxide-induced tongue carcinomas in rats. Jpn J Cancer Res 1996;87:1097-1101.
8. Tanuma J, Shisa H, Hiai H, Higashi S, Yamada H, Kamoto T, Hirayama Y, Matsuuchi H, Kitano M: Quantitative trait loci affecting 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in the rat. Cancer Res 1998;58:1660-1664.
9. Tanuma J, Kitano M, Shisa H, Hiai H: Polygenetic susceptibility and resistance to 4-nitroquinoline 1-oxide-induced tongue carcinomas in the rat. J Exp Anim Sci 2000;41:68-77.
10. Tanuma J, Fujii K, Hirano H, Matsuuchi H, Shisa H, Hiai H, Kitano M: Five quantitative trait loci affecting 4-nitroquinoline 1-oxide-induced tongue cancer in the rat. Jpn J Cancer Res 2001;92:610-616.
11. Yamada Y, Matsushiro H, Ogawa MS, Okamoto K, Nakakuki Y, Toyokuni S, Fukumoto M, Hiai H: Genetic predisposition to pre-B lymphomas in SL/Kh strain mice. Cancer Res 1994;54:403-407.
12. Basten CJ, Weir BS, Zeng ZB: QTL Cartographer Version: A Reference Manual and Tutorial for QTL Mapping. Program in Statistical Genetics. Raleigh, Department of Statistics, North Carolina University, 1999, pp 1-132.
13. Lander ES, Kruglyak L: Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995;11:241-247.
14. Jacob H, Brown DM, Bunker RK, Daly MJ, Dzau VJ, Goodman A, Koike G, Kern V, Kurtz T, Lernmark A, Levan G, Mao Y, Petterson A, Pravenec M, Simon JS, Szpirer C, Szpirer J, Trolliet MR, Winer ES, Lander ES: A genetic linkage map of the laboratory rat, Rattus norvegicus. Nat Genet 1995;9:63-69.
15. Watanabe TK, Bihoreau MT, McCarthy LC, Kiguwa SL, Hishigaki H, Tsuji A, Browne J, Yamasaki Y, Mizoguchi-Miyakita A, Oga K, Ono T, Okuno S, Kanemoto N, Takahashi E, Tomita K, Hayashi H, Adachi M, Webber C, Davis M, Kiel S, Knights C, Smith A, Critcher R, Miller J, Thangarajah T, Day PJ, Hudson JR Jr, Irie Y, Takagi T, Nakamura Y, Goodfellow PN, Lathrop GM, Tanigami A, James MR: A radiation hybrid map of the rat genome containing 5,255 markers. Nat Genet 1999;22:27-36.
16. Tanuma J, Hiai H, Shisa H, Hirano M, Semba I, Nagaoka S, Kitano M: Carcinogenesis modifier loci in rat tongue are subject to frequent loss of heterozygosity. Int J Cancer 2002;102:638-642.
17. Malkinson AM, Nesbitt MN, Skamene E: Susceptibility to urethan-induced pulmonary adenomas between A/J and C57BL/6J mice: use of AXB and BXA recombinant inbred lines indicating a three-locus genetic model. J Natl Cancer Inst 1985;75:971-974.
18. Lee GH, Matsushita H, Kitagawa T: Fine chromosomal localization of the mouse Par2 gene that confers resistance against urethane-induction of pulmonary adenomas. Oncogene 2001;20:3979-3985.
19. Manenti G, Galbiati F, Gianni-Barrera R, Pettinicchio A, Acevedo A, Dragani TA: Haplotype sharing suggests that a genomic segment containing six genes accounts for the pulmonary adenoma susceptibility 1 (Pas1) locus activity in mice. Oncogene 2004;27;23:4495-4504.
20. De Miglio MR, Pascale RM, Simile MM, Muroni MR, Calvisi DF, Virdis P, Bosinco GM, Frau M, Seddaiu MA, Ladu S, Feo F: Chromosome mapping of multiple loci affecting the genetic predisposition to rat liver carcinogenesis. Cancer Res 2002;62:4459-63.
21. Van Y, Zeng ZZ, Higashi S, Denda A, Konishi Y, Onishi S, Ueno H, Higashi K, Hiai H: Resistance of DRH strain rats to chemical carcinogenesis of liver: genetic analysis of later progression stage. Carcinogenesis 2002;23:189-196.
22. Nagase H, Mao JH, Balmain A: A subset of skin tumour modifier loci determines survival time of tumour-bearing mice. Proc Natl Acad Sci USA 1999;96:15032-15037.
23. Gariboldi M, Peissel B, Fabbri A, Saran A, Zaffaroni D, Falvella FS, Spinola M, Tanuma J, Pazzaglia S, Mancuso MT, Maurichi A, Bartoli C, Cataltepe S, Silverman GA, Pilotti S, Hayashizaki Y, Okazaki Y, Dragani TA: SCCA2-like serpins mediate genetic predisposition to skin tumours. Cancer Res 2003;63:1871-1875.
24. Cohen BS, Estabrook RW: Microsomal electron transport reactions. 1. Interaction of reduced triphosphopyridine nucleotide during the oxidative demethylation of aminopyrine and cytochrome b5 reduction. Arch Biochem Biophys 1971;143:37-45.
25. Lind C, Rase B, Ernster L, Townsend M, Martin D: Strain difference in DT-diaphorase activities. FEBS Lett 1973;37:147-148.
26. Serikawa T, Cui Z, Yokoi N, Kuramoto T, Kondo Y, Kitada K, Guenet JL: A comparative genetic map of rat, mouse and human genomes. Exp Anim 1998;47:1-9.
27. Becker-Follmann J, Gaa A, Bausch E, Natt E, Scherer G, Von Deimling O: High-resolution mapping of a linkage group on mouse chromosome 8 conserved on human chromosome 16Q. Mamm Genome 1997;8:172-177.
28. Chen H, Lum A, Seifried A, Wilkens LR, Marchand LL: Association of NAD(P)H: quinone oxidoreductase 609C-T polymorphism with a decreased lung cancer risk. Cancer Res 1999;59:3045-3048.
29. Hirano M: Polymorphism of NQO1 (C609T) in relation to susceptibility to oral squamous cell carcinoma. Oral Med Pathol 2003;8:37-41.
30. Hirano M, Tanuma J, Hirayama Y, Ohyama M, Semba I, Wakusawa S, Shisa H, Hiai H, Kitano M: A speed congenic rat strain bearing the tongue cancer susceptibility locus Tscc1 from Dark-Agouti rats. Cancer Lett 2005, in press.
31. Serikawa T, Cui Z, Yokoi N, Kuramoto T, Kondo Y, Kitada K, Guenet JL: A comparative genetic map of rat, mouse and human genomes. Exp Anim 1998;47:1-9.
32. Rampersaud A, Walz FG Jr: Mapping of genes for cytochromes P-450b, P450e, P-450g, and P-450h in the rat. J Biol Chem 1987;262:5649-5663.
33. Balasubramanian S, Ahmad N, Jeedigunta S, Mukhtar H: Alterations in cell cycle regulation in mouse skin tumours. Biochem Biophys Res Commun 1998;243:744-748.
34. Watanabe H, Pan ZQ, Schreiber AN, DePinho RA, Hurwitz J, Xiong Y: Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen. Proc Natl Acad Sci USA 1998;95:1392-1397.
35. Suzui M, Yoshimi N, Tanka T, Mori H: Infrequent Ha-ras mutation and absence of Ki-ras, N-ras, and p53 mutations in 4-nitroquinoline 1-oxide-induced rat oral lesions. Mol Carcinog 1995;14:294-298.
36. Gollahon LS, Chen A, Aldaz CM: Loss of heterozygosity at chromosome Iq loci in rat mammary tumours. Mol Carcinog 1995;12:7-13.
37. Lee CCR, Yamamoto S, Wanibuchi H, Wada S, Sugimura K, Kishimoto T, Fukushima S: Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumour suppressor genes, and cell proliferation. Cancer Res 1997;57:4765-4776.
38. Sciacca L, Costantino A, Pandini G, Mineo R, Frasca F, Scalia P, Sbraccia PD, Goldfine I, Vigneri R, Belfiore A: Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism. Oncogene 1999;18:2471-2479.
39. Li TJ, Hirayama Y, Kitano M: Glutathione S-transferase π class as a tumour marker in lingual preneoplastic and neoplastic lesions of rats. Virchows Arch 1997;431:37-43.
40. Matsuda R, Yoshida MC, Sakaki M, Okuda A, Sakai M, Muramatsu M: Location of the gene for glutathione S-transferase π on rat chromosome 1 at band q43. Jpn J Cancer Res 1986;77:1055-1058.
41. Donnelly MJ, Patel V, Yeudall WA, Game SM, Scully C, Prime SS: Autocrine production of TGF-α and TGF-β during tumour progression of rat oral keratinocytes. Carcinogenesis 1993;14:981-985.
42. Wong DT: TGF-alpha and oral carcinogenesis. Eur J Cancer B Oral Oncol 1993;29B:3-7.
43. Nomura H, Sawada Y, Fujinaga K, Ohtaki S: Cloning and characterization of rat p27Kip1, a cyclin-dependent kinase inhibitor. Gene 1997;192:211-218.
44. Hegi ME, Devereux TR, Dietrich WF, Cochran CJ, Lander ES, Foley JF, Maronpot RR, Anderson MW, Wiseman RW: Allelotype analysis of mouse lung carcinomas reveals frequent allelic losses on chromosome 4 and an association between allelic imbalances on chromosome 6 and K-ras activation. Cancer Res 1994;54:6257-6264.
45. Zhang Z, Wag Y, Vikis HG, Johnson L, Liu G, Li J, Anderson MW, Sills RC, Hong HL, Devereux TR, Jacks T, Guan KL, You M: Wild-type Kras2 inhibit lung carcinogenesis in mice. Nat Genet 2001;29:25-33.
46. Takahashi M, Ritz J, Cooper GM: Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell 1985;42:581-588.
47. Lee SW, Fang L, Igarashi M, Ouchi T, Lu KP, Aaronson SA: Sustained activation of Ras/Raf/ mitogen-activated protein kinase cascade by the tumour suppressor p53. Proc Natl Acad Sci USA 2000;97:8302-8305.
48. Heath DA, Senior PV, Varley JM, Beck F: Parathyroid-hormone-related protein in tumours associated with hypercalcaemia. Lancet 1990;335:66-69.
49. Iwamura M, di Sant'Agnese PA, Wu G, Benning CM, Cockett AT, Deftos LJ, Abrahamsson PA: Immunohistochemical localization of parathyroid hormone-related protein in human prostate cancer. Cancer Res 1993;53:1724-1726.
50. Manenti G, Peissel B, Gariboldi M, Falvella FS, Zaffaroni D, Allaria B, Pazzaglia S, Rebessi S, Covelli V, Saran A, Dragani TA: A cancer modifier role for parathyroid hormone-related protein. Oncogene 2000;19:5324-5328.
51. Ohyama M, Hirayama Y, Tanuma J, Hirano M, Semba I, Shisa H, Hiai H, Sugihara K, Kitano M: Expression of junB and c-fos are enhanced 4-nitroquinoline 1-oxide-induced rat tongue cancers. Pathol Int 2004;54:35-40.
52. Neyns B, Katesuwansing, Vermeij J, Bourgain C, Vandamme B, Amfo K, Lissens W, DeSutter P, Hooghe PE, DeGreve J: Expression of jun family of genes in human ovarian and normal ovarian surface epithelium. Oncogene 1996;12:1247-1257.